Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

352 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.
Arend WP, Dayer JM. Arend WP, et al. Among authors: dayer jm. Arthritis Rheum. 1990 Mar;33(3):305-15. doi: 10.1002/art.1780330302. Arthritis Rheum. 1990. PMID: 2180403 Review.
The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
Smeets TJ, Dayer JM, Kraan MC, Versendaal J, Chicheportiche R, Breedveld FC, Tak PP. Smeets TJ, et al. Among authors: dayer jm. Arthritis Rheum. 2000 Feb;43(2):270-4. doi: 10.1002/1529-0131(200002)43:2<270::AID-ANR5>3.0.CO;2-H. Arthritis Rheum. 2000. PMID: 10693865
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Breedveld FC, Dayer JM. Breedveld FC, et al. Among authors: dayer jm. Ann Rheum Dis. 2000 Nov;59(11):841-9. doi: 10.1136/ard.59.11.841. Ann Rheum Dis. 2000. PMID: 11053058 Free PMC article. Review.
Cytokines and other mediators in rheumatoid arthritis.
Dayer JM, Demczuk S. Dayer JM, et al. Springer Semin Immunopathol. 1984;7(4):387-413. doi: 10.1007/BF00201968. Springer Semin Immunopathol. 1984. PMID: 6395411 Review. No abstract available.
[Destruction and inflammation of the joints in rheumatoid arthritis: a pathogenic hypothesis (author's transl)].
Dayer JM, Héron JF. Dayer JM, et al. Nouv Presse Med. 1981 Mar 21;10(13):1065-8. Nouv Presse Med. 1981. PMID: 6261219 French.
Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.
Arend WP, Dayer JM. Arend WP, et al. Among authors: dayer jm. Arthritis Rheum. 1995 Feb;38(2):151-60. doi: 10.1002/art.1780380202. Arthritis Rheum. 1995. PMID: 7848304 Review.
Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications.
Chikanza IC, Roux-Lombard P, Dayer JM, Panayi GS. Chikanza IC, et al. Among authors: dayer jm. Arthritis Rheum. 1995 May;38(5):642-8. doi: 10.1002/art.1780380511. Arthritis Rheum. 1995. PMID: 7748221
Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures.
Yaron I, Meyer FA, Dayer JM, Bleiberg I, Yaron M. Yaron I, et al. Among authors: dayer jm. Arthritis Rheum. 1989 Feb;32(2):173-80. doi: 10.1002/anr.1780320210. Arthritis Rheum. 1989. PMID: 2493252
Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis.
Rooney T, Murphy E, Benito M, Roux-Lombard P, FitzGerald O, Dayer JM, Bresnihan B. Rooney T, et al. Among authors: dayer jm. Ann Rheum Dis. 2004 Nov;63(11):1393-8. doi: 10.1136/ard.2003.016428. Ann Rheum Dis. 2004. PMID: 15479888 Free PMC article.
[Mechanisms of articular destruction in rheumatoid arthritis].
Dayer JM. Dayer JM. Rev Med Brux. 1985 Apr;6(4):311-3. Rev Med Brux. 1985. PMID: 4001666 French. No abstract available.
352 results
Jump to page
Feedback